期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

肺腺癌分子分型的研究进展 被引量：4

原文传递
导出
摘要 腺癌是非小细胞肺癌（NSCLC）中常见的类型之一，2004版WHO肺癌病理与遗传学分类根据形态学特征将肺腺癌分为10个组织学亚型。虽然从组织学上看，低分化腺癌患者更常见淋巴结转移以及术后复发；乳头状结构、高组织学级别、核分裂象的增多以及肿瘤的广泛坏死等都是预后不良的指标。然而各亚型和预后之间没有明确的对应关系，组织学亚型通常缺乏明确的预后价值。
作者 徐方平 刘艳辉 庄恒国
机构地区 广东省人民医院病理科
出处 《中华病理学杂志》 CAS CSCD 北大核心 2008年第3期190-192,共3页 Chinese Journal of Pathology
关键词 肺腺癌 分子分型 组织学亚型 非小细胞肺癌 预后不良 形态学特征 淋巴结转移 乳头状结构
分类号 R686 [医药卫生—骨科学]
  • 相关文献

参考文献23

  • 1Travis WD, Brambilla E, MuUer-Hermelink HK, et al. World Health Organization classification of tumors. Pathology and genetics of tumors of the lung, pleura, thymus and heart. Lyon: IARC Press, 2004:35-44. 被引量：1
  • 2Naruke T,Goya T, Tsuchiya R, et al. Prognosis and survival in resected lung carcinoma based on the new international staging system. J Thorac Cardiovasc Surg, 1988, 96(3 ) :440-447. 被引量：1
  • 3Perez-Enciso M, Tenenhaus M. Prediction of clinical outcome with microarray data: a partial least squares discriminant analysis (PLS-DA) approach. Hum Genet, 2003, 112(5-6) :581-592. 被引量：1
  • 4Kallioniemi AK, Kallioniemi OP, Sudar D. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science, 1992, 258(5083) :818-821. 被引量：1
  • 5Pinkel D, Segraves R, Sudar D, et al. High resolution analysis of DNA copy number variation using comparative genomichybridization to microarrays. Nat Genet, 1998, 20 (2) : 207-211. 被引量：1
  • 6Meyerson M, Carbone D. Genomic and proteomic profiling of lung cancers : lung cancer classification in the age of targeted therapy. J Clin Oncol, 2005, 23(14) :3219-3226. 被引量：1
  • 7Garber ME, Troyanskaya OG, Schluens K, et al. Diversity of gene expression in adenocarcinoma of the lung. Proc Natl Acad Sci U S A, 2001,98(24) :13784-13789. 被引量：1
  • 8Bhattacharjee A, Treyanskaya OG, Schluens K, et al. Classification of human lung carcinomas by mRNA expression prefiling reveals distinct adenocarcinoma subclasses. Prec Nail Acad Sci U S A, 2001, 98(24) :13790-13795. 被引量：1
  • 9Takeuchi T, Tomida S, Yatabe Y, et al. Expression profiledefined classification of lung adenocarcinoma shows close relationship with underlying major genetic changes and clinicopathologic behaviors. J Clin Oncol, 2006, 24 ( 11 ) : 1679- 1688. 被引量：1
  • 10Hayes DN, Monti S, Parmigiani G, et al. Gene expression profiling reveals reproducible human lung adenocarcinoma subtypes in multiple independent patient cohorts. J Clin Oncol, 2006, 24 (31) :5079-5090. 被引量：1

二级参考文献20

  • 1Jaffe ES,Harris NL,Stein H,et al.Eds.World Health Organization classification of tumors.Pathlogy and genetics of tumours of haematopoietic and lymphoid Tissues.Lyon:IARC Press,2001.171-187. 被引量：1
  • 2The International non-Hodgkin's lymphoma Prognostic Factors Project.A predictive model for aggressive non-Hodgkin's lymphoma.N Engl J Med,1993,329:987-994. 被引量：1
  • 3Alizadeh AA,Eisen MB,Davis ER,et al.Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling.Nature,2000,403:503-511. 被引量：1
  • 4Rosenwald A,Wright G,Chan WC,et al.The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.N Engl J Med,2002,346:1937-1947. 被引量：1
  • 5Lossos IS,Alizadeh AA,Eisen MB,et al.Ongoing immunoglobulin somatic mutation in germinal center B cell-like but not in activated B cell-like diffuse large cell lymphomas.Proc Natl Acad Sci U S A,2000,97:10209-10213. 被引量：1
  • 6Huang JZ,Sanger WG,Greiner TC,et al.The t(14;18) defines a unique subset of diffuse large B-cell lymphoma with a germinal center B-cell gene expression profile.Blood,2002,99:2285-2290. 被引量：1
  • 7Iqbal J,Sanger WG,Horsman DE,et al.Bcl2 translocation defines a unique tumor subset with in the germinal center B-cell-like diffuse large B-cell lymphoma.Am J Pathol,2004,165:159-166. 被引量：1
  • 8Davis RE,Brown KD,Siebenlist U,et al.Constitutive nuclear factor kB activity is required for survival of activated B cell-like diffuse large B-cell lymphoma cells.J Exp Med,2001,194:1861-1874. 被引量：1
  • 9Lu XQ,Nechushtan H,Ding FY,et al.Distinct IL-4-induced gene expression,proliferation,and intracellular signaling in germinal center B-cell like and activated B-cell-like diffuse large-cell lymphomas.Blood,2005,105:2924-2932. 被引量：1
  • 10Savage KJ,Monti S,Kutok JL,et al.The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma.Blood,2003,102:3871-3879. 被引量：1

共引文献11

同被引文献58

  • 1王之敏,陶承.恶性脑胶质瘤分子靶向治疗研究进展[J].中国肿瘤,2006,15(3):158-162. 被引量：3
  • 2方家椿.分子靶点和分子靶向抗肿瘤药研究进展[J].北京大学学报（医学版）,2006,38(6):575-578. 被引量：12
  • 3汪世容,关柏林.转化医学:B2B医疗新模式.文汇报,2008-11-08(7). 被引量：1
  • 4Vanden Bempt I, Van Loo P, Drijkoningen M, et al. Polysomy 17 in breast cancer: clinicopathologic significance and impact on HER-2 testing. J Clin Oncol, 2008, 26(30) :4869-4874. 被引量：1
  • 5Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon: IARC Press, 2008 : 233-237. 被引量：1
  • 6Feder JN, Gnirke A, Thomas W, et al. A novel MHC class 1-like gene is mutated in patients with hereditary haemochromatosis. Nat Genet, 1996, 13(4):399-408. 被引量：1
  • 7Debiec-Rychter M, Sciot R, Le Cesne A, et al. KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours. Eur J Cancer, 2006, 42 ( 8 ) : 1093-1103. 被引量：1
  • 8Cobo M, Isla D, Massuti B, et al. Customizing cisplatin based on quantitative excision repair cross-complementing 1 mRNA expression: a phase Ⅲ trial in non-small-cell lung cancer. J Clin Oncol, 2007, 25(19):2747-2754. 被引量：1
  • 9Olaussen KA, Dunant A, Fouret P, et al. DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. N Engl J Med, 2006, 355(10) :983-991. 被引量：1
  • 10Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature, 2008, 455 (7216) : 1061-1068. 被引量：1

引证文献4

二级引证文献8

中华病理学杂志
2008年 第3期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部